Search research articles
Contact Us
Filters
Showing results (11-20 of 63) with videos related to
Page
of 7
Sort By:
Gynecologie, Obstetrique & Fertilite
|
August 23, 2011
[Gynaecologists' attitudes and practices towards HPV vaccination: a quantitative-qualitative study in Rhône-Alpes]
D Lutringer-Magnin, J Kalecinski, G Barone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1996
Clinical relevance of CD44 cell-surface expression and N-myc gene amplification in a multicentric analysis of 121 pediatric neuroblastomas
V Combaret, N Gross, C Lasset, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 13, 1997
Response rate accuracy in oncology trials: reasons for interobserver variability. Groupe Français d'Immunothérapie of the Fédération Nationale des Centres de Lutte Contre le Cancer
P Thiesse, L Ollivier, D Di Stefano-Louineau, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 28, 1998
Clinical relevance of CD44 cell surface expression and MYCN gene amplification in neuroblastoma
V Combaret, N Gross, C Lasset, et al.
Bulletin Du Cancer
|
January 1, 1995
[CD44 expression: a new prognostic factor in neuroblastoma]
V Combaret, C Lasset, R Bouvier, et al.
American Journal of Medical Genetics
|
September 12, 2000
Disclosure to the family of breast/ovarian cancer genetic test results: patient's willingness and associated factors
C Julian-Reynier, F Eisinger, F Chabal, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1995
Evaluation of CD44 prognostic value in neuroblastoma: comparison with the other prognostic factors
V Combaret, C Lasset, D Frappaz, et al.
Bulletin Du Cancer
|
July 27, 1999
[Cervical cancer screening for high risk women: is it possible? Results of a cervical cancer screening program in three suburban districts of Lyon]
H Mignotte, D Perol, B Fontanière, et al.
Bulletin Du Cancer
|
January 1, 1990
[Prognostic factors in the response of a first line chemotherapy in advanced breast cancer]
F Chauvin, M Magnet, C Lasset, et al.
Vaccine
|
September 10, 2013
HPV vaccination among French girls and women aged 14-23 years and the relationship with their mothers' uptake of Pap smear screening: a study in general practice
D Lutringer-Magnin, C Cropet, G Barone, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 63) with videos related to
Sort By:
Page
of 7
Gynecologie, Obstetrique & Fertilite
|
August 23, 2011
[Gynaecologists' attitudes and practices towards HPV vaccination: a quantitative-qualitative study in Rhône-Alpes]
D Lutringer-Magnin, J Kalecinski, G Barone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1996
Clinical relevance of CD44 cell-surface expression and N-myc gene amplification in a multicentric analysis of 121 pediatric neuroblastomas
V Combaret, N Gross, C Lasset, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 13, 1997
Response rate accuracy in oncology trials: reasons for interobserver variability. Groupe Français d'Immunothérapie of the Fédération Nationale des Centres de Lutte Contre le Cancer
P Thiesse, L Ollivier, D Di Stefano-Louineau, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 28, 1998
Clinical relevance of CD44 cell surface expression and MYCN gene amplification in neuroblastoma
V Combaret, N Gross, C Lasset, et al.
Bulletin Du Cancer
|
January 1, 1995
[CD44 expression: a new prognostic factor in neuroblastoma]
V Combaret, C Lasset, R Bouvier, et al.
American Journal of Medical Genetics
|
September 12, 2000
Disclosure to the family of breast/ovarian cancer genetic test results: patient's willingness and associated factors
C Julian-Reynier, F Eisinger, F Chabal, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1995
Evaluation of CD44 prognostic value in neuroblastoma: comparison with the other prognostic factors
V Combaret, C Lasset, D Frappaz, et al.
Bulletin Du Cancer
|
July 27, 1999
[Cervical cancer screening for high risk women: is it possible? Results of a cervical cancer screening program in three suburban districts of Lyon]
H Mignotte, D Perol, B Fontanière, et al.
Bulletin Du Cancer
|
January 1, 1990
[Prognostic factors in the response of a first line chemotherapy in advanced breast cancer]
F Chauvin, M Magnet, C Lasset, et al.
Vaccine
|
September 10, 2013
HPV vaccination among French girls and women aged 14-23 years and the relationship with their mothers' uptake of Pap smear screening: a study in general practice
D Lutringer-Magnin, C Cropet, G Barone, et al.
Page
of 7